MTFB Motif Bio PDUFA Iclaprim

When: February 13, 2019 all-day

On Aug. 14, 2018 Motif Bio plc $MTFB, a clinical-stage biopharmaceutical company specializing in developing novel antibiotics announced that the FDA had accepted their filing of the New Drug Application[…]